NRIX Reports $540.7M Cash, Launches $50M Buyback, Advances Bexobrutideg Phase 3, Targets 2026 INDs
Nurix Therapeutics, Inc. Common stock · PHARMACEUTICAL PREPARATIONS · Now $17.39
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS